Advertisement
Screener

NOMAD POWER SOLUTIONS, INC. (NMAD) Overview

NOMAD POWER SOLUTIONS, INC. (NMAD) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual -0.16; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual -0.18; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual -0.33; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual -0.29; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$2.32$3.00$3.89$5.03$6.52$8.442025-11-062026-11-06$0.67$1.40$2.92$6.07$12.62$26.252021-11-082026-11-06$0.67$1.77$4.67$12.29$32.32$85.052016-11-072026-11-06$0.67$1.77$4.67$12.29$32.32$85.052007-10-252026-11-06$0.67$1.77$4.67$12.29$32.32$85.052007-10-252026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$3.62
Previous close
$3.75
Change
-$0.13
Change (%)
-3.47%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

NMAD
-4.58%
S&P 500
(m)

1 year

NMAD
-27.75%
S&P 500
(m)

3 years

NMAD
+53.06%
S&P 500
(m)

5 years

NMAD
-81.62%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual -0.16

-0.41-0.30-0.20-0.090.0231 Mar 2025: estimate (m); actual -0.2931 Mar 2025(m)30 Jun 2025: estimate (m); actual -0.2930 Jun 2025(m)30 Sept 2025: estimate (m); actual -0.3330 Sept 2025(m)31 Mar 2026: estimate (m); actual -0.1831 Mar 2026(m)30 Jun 2026: estimate (m); actual -0.1630 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)-0.16(m)(m)
1 Jan 202631 Mar 2026(m)-0.18(m)(m)
1 Jul 202530 Sept 2025(m)-0.33(m)(m)
1 Apr 202530 Jun 2025(m)-0.29(m)(m)
1 Jan 202531 Mar 2025(m)-0.29(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual -1.26

-4.07-3.32-2.58-1.83-1.0831 Dec 2022: estimate (m); actual -3.9931 Dec 2022(m)31 Dec 2023: estimate (m); actual -2.6631 Dec 2023(m)31 Dec 2024: estimate (m); actual -1.5931 Dec 2024(m)31 Dec 2025: estimate (m); actual -1.2631 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)-1.26(m)(m)
1 Jan 202431 Dec 2024(m)-1.59(m)(m)
1 Jan 202331 Dec 2023(m)-2.66(m)(m)
1 Jan 202231 Dec 2022(m)-3.99(m)(m)

Revenue vs. Earnings

USD

30 Sept 2013 ■ Revenue 0.00M ■ Earnings -0.31M — Profit margin (m)

-2.22M-1.40M-0.58M0.24M30 Sept 2012: revenue 0.00M; earnings -1.98M; profit margin (m)30 Sept 201231 Mar 2013: revenue 0.00M; earnings -0.33M; profit margin (m)31 Mar 201330 Jun 2013: revenue 0.00M; earnings -0.37M; profit margin (m)30 Jun 201330 Sept 2013: revenue 0.00M; earnings -0.31M; profit margin (m)30 Sept 2013

31 Dec 2015 ■ Revenue 0.20M ■ Earnings -2.85M — Profit margin -1426.05%

-4.03M-1427.1%-2.47M-1426.4%-0.91M-1425.7%0.65M-1425.1%31 Dec 2011: revenue 0.00M; earnings -2.07M; profit margin (m)31 Dec 201131 Dec 2012: revenue 0.00M; earnings -3.58M; profit margin (m)31 Dec 201231 Dec 2013: revenue 0.00M; earnings -1.37M; profit margin (m)31 Dec 201331 Dec 2015: revenue 0.20M; earnings -2.85M; profit margin -1426.05%31 Dec 2015

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$3.62(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$3.62High(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning NMAD

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-13; financial period ending (m).

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
(m)
Profit margin
(m)
Return on assets · 12 month
(m)
Stock compensation expense · all employees · 12 months
(m)
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
Employees
(m)
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
229.20K
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
-1.83%*
Total return · month
-12.99%*
Total return · quarter
-53.36%*
Total return · half year
21.36%*
Total return · year to date
-4.58%*
Total return · 1 year
-27.75%*
Total return · 3 years
53.06%*
Total return · 5 years
-81.62%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
(m)
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

NOMAD POWER SOLUTIONS, INC. Overview

View more →

(m)

(m)

SEC CIK
1335105
Industry (SIC)
2834 Pharmaceutical Preparations
Country of operation
United States
Business address
433 PLAZA REAL, SUITE 275, BOCA RATON, Florida, 33432, United States
Fiscal year end
1231
Phone
310 203 2902

Similar stocks

Stock NameCountryMarket CapPE Ratio
Boundless Bio, Inc. (BOLD)United States$0.059B-0.88
Annovis Bio, Inc. (ANVS)United States$0.056B-1.58
TALPHERA, INC. (TLPH)United States$0.060B
CalciMedica, Inc. (CALC)United States$0.061B-1.42
Skye Bioscience, Inc. (SKYE)United States$0.061B-0.48
HERON THERAPEUTICS, INC. /DE/ (HRTX)United States$0.055B-2.38
Clene Inc. (CLNN)United States$0.054B-1.99
Serina Therapeutics, Inc. (SER)United States$0.054B-2.35
Rein Therapeutics, Inc. (RNTX)United States$0.063B-1.76
Xilio Therapeutics, Inc. (XLO)United States$0.052B